Biotech

All Articles

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH possibility

.Novo Nordisk has axed its own once-monthly double GLP-1/ GIP receptor agonist, ending (PDF) advance...

Daiichi pays for Merck $170M to create lung cancer T-cell engager contract

.Merck &amp Co. has actually swiftly made back some of the costs of its Weapon Therapeutics purchase...

BioMarin standstills preclinical gene therapy for heart disease

.After BioMarin conducted a spring tidy of its pipeline in April, the business has actually decided ...

Eisai plants molecular adhesive SEED with $1.5 B biobucks deal

.Major Pharmas stay stuck to the suggestion of molecular glue degraders. The most up to date provide...

Life scientific research credit rating company unveils along with $600M

.A brand new global life science credit organization, nicknamed Symbiotic Capital, has reared much m...

BMS channels TIGIT, bowing out $200M bet on Agenus bispecific

.Bristol Myers Squibb is actually axing another large wager from the Caforio age, terminating a barg...

Nuvation stops BET inhibitor after considering period 1 record

.After checking out at phase 1 information, Nuvation Bio has actually decided to halt service its ow...

' Professional instinct' led FDA specialists to support Zevra's unusual illness med

.Zevra Therapeutics' rare disease drug seems to be on the course to permission this loss after obtai...

Pfizer takes $230M struck after axing stopped working DMD gene treatment

.Pfizer's phase 3 Duchenne muscle dystrophy (DMD) genetics treatment failing has gone a $230 thousan...

AC Immune views 'spots' possible in Alzheimer's medication information

.After much more than 20 years of work on neurodegenerative illness, Swiss biotech air conditioner I...